Dr. Constantine emphasized that while many people use cannabis without dependency, others face significant withdrawal ...

Please provide your email address to receive an email when new articles are posted on . AEF0117 decreased cannabis use and positive mood effects in daily users. The drug was also well tolerated and ...

Despite the need, there are no FDA-approved medications to treat cannabis use disorder. AEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors ...

BORDEAUX, France — Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy ...

Financing led by Biotech Specialist Funds and a Generalist with significant participation from Series A investors  Proceeds ...

A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor shows promise as a safe and effective treatment for cannabis use disorder (CUD), a condition ...

January 31, 2008 — Cannabis withdrawal is clinically important and warrants inclusion in the Diagnostic and Statistical Manual (DSM), researchers argue in an article in the January 1 issue of Drug and ...

Cannabis use disorder (CUD), also known as marijuana use disorder, is defined by compulsive use of cannabis despite adverse consequences, difficulty controlling use, and withdrawal symptoms. The ...

Most users perceive marijuana as a healthy, natural plant. It's touted as a cure or treatment for pain, anxiety, seizures, and other various ailments. Yet, much of this is false. Dr. Roneet Lev, a ...

As a general psychiatrist and addiction psychiatrist, I’m asked all the time about my opinions on cannabis, and what I think the pros and cons of marijuana use are for individual or public health.

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...